Clinical Trial

MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery

Study acronym: MICROSURG
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 5, 2026 (before its estimated May 18, 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical study investigates how the subgingival microbiome changes after three different periodontal and peri-implant surgical procedures: (1) resective periodontal surgery, (2) regenerative periodontal surgery, and (3) peri-implantitis surgery. The aim is to characterize microbial shifts associated with these commonly used surgical treatments and to determine whether the type of surgery influences the recovery or disruption of the subgingival ecosystem. Adult patients with periodontitis or peri-implantitis will receive the procedure indicated for their condition. Subgingival plaque samples will be collected at baseline and at defined postoperative follow-up intervals. Microbiome analysis will be performed using next-generation sequencing (NGS), and microbial changes will be evaluated with the Subgingival Microbial Dysbiosis Index (SMDI). Insights from this study may help improve prevention, diagnostics, and treatment strategies for periodontal and peri-implant diseases.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-05-06
notable Primary completion pushed: 2026-03-01 -> 2026-05-18 2026-05-06
minor Completion pushed: 2026-04-01 -> 2026-06-01 2026-05-06
Trial Details
NCT Number NCT07414498
Lead Sponsor University Hospital Muenster
Collaborators: dfg
Conditions Periodontitis, Periimplantitis
Enrollment 84 participants
Start Date 2026-02-23
Primary Completion 2026-05-18 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-05